• Profile
Close

Serum pepsinogen as a predictor for gastric cancer death: A 16-year community-based cohort study

Journal of Clinical Gastroenterology Apr 11, 2019

Chiang TH, et al. - The long-term association between initial serum pepsinogen (PG) measurements and subsequent gastric cancer-specific deaths from long-term longitudinal cohort was validated by researchers in this analysis. In order to determine serum PG levels, 1682 (47.9%) were screened among participants (n=3514) aged ≥30 years. Fourteen deaths from gastric cancer were documented after 16 years of follow-up. Multivariate analyses adjusted for age, sex, and Helicobacter pylori serological positivity exhibited that PG-I <30 μg/L and PG-I <30 μg/L or PG-I/II ratio <3 were significantly related to the risk of gastric cancer death. There were, on the other hand, no significant associations between PG and other death causes, including neoplastic and non-neoplastic diseases. This long-term cohort study demonstrates the usefulness of measuring PG as a biomarker specific to the risk of death from gastric cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay